Serum S100A12 levels were the highest in untreated FMF patientsS100A12 decreased significantly after introduction of colchicine therapySerum concentrations of S100A12 was significantly higher in patients with persistent symptoms than in those with clinically controlled disease. This evidence concerns the gene S100A12 and familial Mediterranean fever.